Efaproxiral Sodium
Efaproxiral Sodium (RSR13 sodium) is a synthetic small molecule allosteric effector of hemoglobin. It has been investigated in preclinical and clinical research for its potential to sensitize hypoxic tumors, such as breast cancer-derived brain metastases, to radiation therapy.
Product Specifications
CAS Number
170787-99-2
Product Name Alternative
Efaproxiral, Efaproxiral Sodium, hemoglobin, Inhibitor, inhibit, ReactiveOxygenSpecies, Reactive Oxygen Species, RSR-13, RSR13, RSR13 sodium, RSR 13
Field of Research
Immunology & Inflammation, Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
97.92% (May vary between batches)
Solubility
H2O:67 mg/mL (184.38 mM) ; DMSO:68 mg/mL (187.13 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.5 mM) ; Ethanol:68 mg/mL (187.13 mM)
Smiles
[Na+].Cc1cc (C) cc (NC (=O) Cc2ccc (OC (C) (C) C ([O-]) =O) cc2) c1
Molecular Formula
C20H23NO4·Na
Molecular Weight
363.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TGS1 sgRNA CRISPR Lentivector (Human) (Target 2)
